Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
163.80    -1.20 (-0.73%)
Bid:
164.20
Ask:
165.00
Spread: 0.80 (0.487%)
Market Cap: £399.18m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Directorate Change

31 Jul 2025 07:01

RNS Number : 2646T
Sabre Insurance Group PLC
31 July 2025
 

31 July 2025

SABRE INSURANCE GROUP PLC

Appointment of Non-executive Director

 

Sabre Insurance Group plc (the "Group" or "Sabre") is pleased to announce the appointment to the Board of David Neave as a Non-executive Director, with effect from 1 August 2025. On appointment, David will join Sabre's Audit and Remuneration Committees.

 

David is a seasoned insurance professional with extensive experience in the UK general insurance industry, spanning executive, non-executive and advisory roles. David served as the CEO at Co-operative Insurance between 2005 and 2013, where he led transformation and technology initiatives. Prior to that, he spent twenty-five years in various positions at Royal Insurance/RSA, where he finished as the Claims Service Director for UK Claims. More recently, David has served as a Non-executive Director on the Board of Direct Line Insurance Group plc and has held non-executive positions at the insurer LV= (and Chair of their General Insurance Board), Slater and Gordon UK Limited (where he chaired the Audit and Risk Committee), and Solicitors' Indemnity Fund. He has also held advisory roles at Accenture UK, the Insurance Fraud Bureau and the Association of British Insurers. David is currently the Chair of the Advisory Board at CAPS and is a Fellow of the Chartered Insurance Institute.

 

Rebecca Shelley, Sabre's Chair, commented:

"David's extensive insurance knowledge and experience will add significant value to Sabre, as we continue to work towards achieving our Ambition 2030 objectives. I am delighted to welcome him to the Board and look forward to working with him."

 

Pursuant to Listing Rule 9.6.13R, it is confirmed there are no other disclosures required in addition to the above information.

 

Enquiries

Teneo

James Macey White

Ffion Dash

020 7353 4200

sabre@teneo.com

 

 

LEI Code: 2138006RXRQ8P8VKGV98

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGZGFNVGNGKZM
Date   Source Headline
3rd Jul 20243:40 pmRNSHolding(s) in Company
19th Jun 202412:28 pmRNSAppointment of Non-executive Director
14th Jun 20249:50 amRNSDirector/PDMR Shareholding
11th Jun 202411:54 amRNSDirector/PDMR Shareholding
11th Jun 202410:17 amRNSDirector/PDMR Shareholding
10th Jun 20244:16 pmRNSHolding(s) in Company
6th Jun 202412:52 pmRNSDirector/PDMR Shareholding
30th May 20242:00 pmRNSDirector/PDMR Shareholding
23rd May 202411:08 amRNSResult of AGM
23rd May 20247:00 amRNSTrading Update
22nd May 20241:59 pmRNSDirector/PDMR Shareholding
21st May 20242:46 pmRNSHolding(s) in Company
20th May 20248:23 amRNSAppointment of Senior Independent Director
15th May 20242:24 pmRNSHolding(s) in Company
13th May 202412:23 pmRNSDirector/PDMR Shareholding
23rd Apr 20244:00 pmRNSHolding(s) in Company
22nd Apr 20243:22 pmRNSHolding(s) in Company
19th Apr 20248:51 amRNSChair Appointment
18th Apr 202411:22 amRNSDirector Declaration
11th Apr 202412:41 pmRNSDirector/PDMR Shareholding
11th Apr 202412:07 pmRNSDirector/PDMR Shareholding
9th Apr 20242:44 pmRNSDirector/PDMR Shareholding
5th Apr 20243:48 pmRNSNotice of AGM
21st Mar 202412:30 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFull-year results 2023
13th Mar 20249:33 amRNSNotice of Results
12th Mar 20242:16 pmRNSDirector/PDMR Shareholding
12th Mar 202412:14 pmRNSDirector Declaration
16th Feb 20241:52 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTrading Statement
13th Feb 20242:18 pmRNSDirector/PDMR Shareholding
11th Jan 202411:11 amRNSDirector/PDMR Shareholding
20th Dec 20232:24 pmRNSHolding(s) in Company
12th Dec 202312:03 pmRNSDirector/PDMR Shareholding
28th Nov 20234:27 pmRNSDirectorate Change
27th Nov 20234:42 pmRNSRemuneration Committee Chair Appointment
22nd Nov 20238:51 amRNSNotification of cyber incident
20th Nov 20237:00 amRNSDeath of Chair
13th Nov 202311:44 amRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSTrading Update
11th Oct 202312:52 pmRNSDirector/PDMR Shareholding
25th Sep 20233:39 pmRNSDirector/PDMR Shareholding
21st Sep 202311:48 amRNSDirector/PDMR Shareholding
14th Sep 20232:25 pmRNSHolding(s) in Company
13th Sep 202310:00 amRNSDirector/PDMR Shareholding
13th Sep 20239:33 amRNSDirectorate Change
11th Aug 202310:07 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSHalf-year Report 2023
25th Jul 20238:53 amRNSDirector Declaration
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.